WikiPathways:NewPathwayReleases

From WikiPathways

(Difference between revisions)
Jump to: navigation, search
(first draft)
Current revision (20:35, 10 January 2023) (view source)
(Jan 2023)
 
(52 intermediate revisions not shown.)
Line 1: Line 1:
-
=== November 2019 Release (20191110)===
+
'''Each month there are new pathways reviewed and approved for the official release of WikiPathways. See the [[Download_Pathways|Download Page]] to access the full collection.'''
-
 
+
===January 2023===
{| style="margin: 10px; background-color:#E4EEF2"
{| style="margin: 10px; background-color:#E4EEF2"
-
|width=100px|{{#pwImage:Pathway:WP506|250px||Fatty Acid Beta Oxidation (Rattus norvegicus)}}
+
|width=100px|{{#pwImage:Pathway:WP5077|250px||Response to acute ibuprofen exposure (Daphnia magna)}}
-
|width=100px|{{#pwImage:Pathway:WP376|250px||Renin - Angiotensin System (Rattus norvegicus)}}
+
|width=100px|{{#pwImage:Pathway:WP5276|250px||Estrogen metabolism (Homo sapiens)}}
-
|width=100px|{{#pwImage:Pathway:WP4722|250px||Glycerolipids and Glycerophospholipids (Homo sapiens)}}
+
|width=100px|{{#pwImage:Pathway:WP5299|250px||Ganglio series sphingolipid metabolism (Homo sapiens)}}
-
|width=100px|{{#pwImage:Pathway:WP4724|250px||Omega-9 FA synthesis (Homo sapiens)}}
+
|width=100px|{{#pwImage:Pathway:WP5303|250px||Lacto series sphingolipid metabolism (Homo sapiens)}}
|-
|-
-
|width=100px|{{#pwImage:Pathway:WP4726|250px||Sphingolipid Metabolism (integrated pathway) (Homo sapiens)}}
+
|width=100px|{{#pwImage:Pathway:WP5280|250px||Glucocorticoid biosynthesis (Homo sapiens)}}
-
|width=100px|{{#pwImage:Pathway:WP4585|250px||Overview of interferons-mediated signaling pathway (Homo sapiens)}}
+
|width=100px|{{#pwImage:Pathway:WP5290|250px||Lipid remodeling (Anopheles gambiae)}}
-
|width=100px|{{#pwimage:Pathway:WP4723|250px||Omega-3/Omega-6 FA synthesis (Homo sapiens)}}
+
|width=100px|{{#pwImage:Pathway:WP5292|250px||Glycosphingolipid metabolism (Homo sapiens)}}
-
|width=100px|{{#pwImage:Pathway:WP4483|250px||Relationship between inflammation, COX-2 and EGFR (Homo sapiens)}}
+
|width=100px|{{#pwImage:Pathway:WP5277|250px||Steroid hormone precursor biosynthesis (Homo sapiens)}}
|-
|-
-
|width=100px|{{#pwimage:Pathway:WP4720|250px||Eicosanoid metabolism via Cytochrome P450 Mono-Oxygenases (CYP) pathway (Homo sapiens)}}
+
|width=100px|{{#pwImage:Pathway:WP5300|250px||TROP2 regulatory signaling (Homo sapiens)}}
-
|width=100px|{{#pwImage:Pathway:WP4742|250px||Ketogenesis and Ketolysis (Homo sapiens)}}
+
|width=100px|{{#pwImage:Pathway:WP5302|250px||Neolacto series sphingolipid metabolism (Homo sapiens)}}
-
|width=100px|{{#pwImage:Pathway:WP4719|250px||Eicosanoid metabolism via Cyclo Oxygenases (COX) (Homo sapiens)}}
+
|width=100px|{{#pwImage:Pathway:WP5279|250px||Mineralocorticoid biosynthesis (Homo sapiens)}}
-
|width=100px|{{#pwImage:Pathway:WP4718|250px||Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) (Homo sapiens)}}
+
|}
 +
===December 2022===
 +
{| style="margin: 10px; background-color:#E4EEF2"
 +
|width=100px|{{#pwImage:Pathway:WP5218|250px||Extrafollicular and follicular B cell activation by SARS-CoV-2 (Homo sapiens)}}
 +
|}
 +
===November 2022===
 +
{| style="margin: 10px; background-color:#E4EEF2"
 +
|width=100px|{{#pwImage:Pathway:WP5078|250px||T cell modulation in pancreatic cancer (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5155|250px||Arachidonic acid (AA, ARA) oxylipin metabolism (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5236|250px||Markers of kidney cell lineage (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5242|250px||Comprehensive IL-17A signaling pathway (Mus musculus)}}
|-
|-
-
|width=100px|{{#pwImage:Pathway:WP4674|250px||Head and Neck Squamous Cell Carcinoma (Homo sapiens)}}
+
|width=100px|{{#pwImage:Pathway:WP5284|250px||Cell interactions of the pancreatic cancer microenvironment (Homo sapiens)}}
-
|width=100px|{{#pwImage:Pathway:WP4721|250px||Eicosanoid metabolism via Lipo Oxygenases (LOX) (Homo sapiens)}}
+
|width=100px|{{#pwImage:Pathway:WP5287|250px||17q12 copy number variation syndrome (Homo sapiens)}}
-
|width=100px|{{#pwImage:Pathway:WP4725|250px||Sphingolipid Metabolism (general overview) (Homo sapiens)}}
+
|width=100px|{{#pwImage:Pathway:WP4936|250px||Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5294|250px||Sildenafil treatment (Homo sapiens)}}
|}
|}
 +
===October 2022===
 +
{| style="margin: 10px; background-color:#E4EEF2"
 +
|width=100px|{{#pwImage:Pathway:WP5283|250px||Chronic hyperglycemia impairment of neuron function (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5237|250px||Serotonin reuptake inhibitor response (Daphnia magna)}}
 +
|width=100px|{{#pwImage:Pathway:WP5256|250px||Endothelial cell senescence (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5275|250px||Ether lipid biosynthesis (Homo sapiens)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5091|250px||Frustrated phagocytosis leading to malignant pleural mesothelioma (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5285|250px||Immune infiltration in pancreatic cancer (Homo sapiens)}}
 +
|}
 +
===September 2022===
 +
{| style="margin: 10px; background-color:#E4EEF2"
 +
|width=100px|{{#pwImage:Pathway:WP782|250px||Triacylglyceride synthesis (Gallus gallus)}}
 +
|}
 +
===August 2022===
 +
{| style="margin: 10px; background-color:#E4EEF2"
 +
|width=100px|{{#pwImage:Pathway:WP5231|250px||Hippocampal synaptogenesis and neurogenesis (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5233|250px||Arsenic metabolism and reactive oxygen species generation (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5234|250px||Bardet-Biedl syndrome (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5235|250px||Estradiol regulation in Porto-Sinusoidal Vascular Disease (Homo sapiens)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5238|250px||Cholestasis (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5265|250px||Neurogenesis regulation in the olfactory epithelium (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5269|250px||Genetic causes of PSVD/INCPH (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5271|250px||Bacterial ceramide synthesis (Caulobacter vibrioides)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5272|250px||LDL- influence on CD14 and TLR4 (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5273|250px||Effect of intestinal microbiome on anticoagulant response of Vitamin K antagonists (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5274|250px||Farnesyl to CoQ10 metabolism (Homo sapiens)}}
 +
|}
 +
===July 2022===
 +
{| style="margin: 10px; background-color:#E4EEF2"
 +
|width=100px|{{#pwImage:Pathway:WP5239|250px||Lac-Phe pathway (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5240|250px||Lac-Phe pathway (Mus musculus)}}
 +
|width=100px|{{#pwImage:Pathway:WP5241|250px||Mitochondrial beta oxidation (Homo sapiens)}}
 +
|}
 +
===June 2022===
 +
{| style="margin: 10px; background-color:#E4EEF2"
 +
|width=100px|{{#pwImage:Pathway:WP5221|250px||2q11.2 copy number variation syndrome (Homo sapiens)}}
 +
|}
 +
===May 2022===
 +
{| style="margin: 10px; background-color:#E4EEF2"
 +
|width=100px|{{#pwImage:Pathway:WP4686|250px||Leucine, isoleucine and valine metabolism (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5220|250px||Metabolic reprogramming in pancreatic cancer (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5222|250px||2q13 copy number variation syndrome (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5223|250px||2q21.1 copy number variation syndrome (Homo sapiens)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5224|250px||2q37 copy number variation syndrome (Homo sapiens)}}
 +
|}
 +
===April 2022===
 +
{| style="margin: 10px; background-color:#E4EEF2"
 +
|width=100px|{{#pwImage:Pathway:WP5154|250px||Docosahexaenoic acid (DHA) oxylipin metabolism (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5171|250px||Metabolic pathway leukotriene (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5180|250px||DYRK1A (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5181|250px||Roles of ceramides in the development of insulin resistance (Homo sapiens)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5182|250px||Pro-survival signaling of neuroprotectin D1 (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5186|250px||Activation of Vitamin K-dependent proteins (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5188|250px||Retinol Metabolism (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5190|250px||Creatine Pathway (Homo sapiens)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5191|250px||ResolvinE1 and ResolvinD1 signaling pathways promoting inflammation resolution (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5192|250px||Modulation of the PI3K-Akt-mTOR signaling by bioactive sphingolipids (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5193|250px||Cholesterol synthesis disorders (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5194|250px||Synthesis of ceramides and 1-deoxyceramides (Homo sapiens)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5196|250px||N-Glycan biosynthesis (Sheep) (Ovis aries)}}
 +
|width=100px|{{#pwImage:Pathway:WP5199|250px||PtdIns(4,5)P2 in cytokinesis pathway (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5200|250px||Dravet syndrome (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5201|250px||Phospholipid biosynthesis (Saccharomyces cerevisiae)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5202|250px||Alstrom syndrome (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5205|250px||Clocked controlled autophagy in bone metabolism (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5211|250px||Glucose metabolism in triple-negative breast cancer cells (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5213|250px||Amino acid metabolism in triple-negative breast cancer cells (Homo sapiens)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5218|250px||Extrafollicular B cell activation by SARS-CoV-2 (Homo sapiens)}}
 +
|}
 +
===March 2022===
 +
{| style="margin: 10px; background-color:#E4EEF2"
 +
|width=100px|{{#pwImage:Pathway:WP5130|250px||Th17 cell differentiation pathway (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5136|250px||ALA oxylipin metabolism (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5137|250px||Linoleic acid oxylipin metabolism (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5143|250px||GDNF signaling (Homo sapiens)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5149|250px||Lipid metabolism in senescent cells (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5166|250px||Glyoxylate metabolism (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5169|250px||Hemesynthesis defects and porphyrias (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5173|250px||Disorders of galactose metabolism (Homo sapiens)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5174|250px||Ulcerative colitis signaling (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5175|250px||Disorders in ketone body synthesis (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5176|250px||Disorders of bile acid synthesis and biliary transport (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5178|250px||Disorders of fructose metabolism (Homo sapiens)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5179|250px||Biosynthesis and turnover of 1-deoxy-sphingoid bases (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5183|250px||SARS-CoV-2 Mediated Endothelial Dysfunction: The Potential Role of Chronic Oxidative Stress in the mitochondria (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5187|250px||mRNA vaccine activation of Dendritic cell and induction of IFN-1 (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5189|250px||Copper metabolism (Homo sapiens)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5195|250px||Disorders in Ketolysis (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5198|250px||Inflammatory bowel disease signaling (Homo sapiens)}}
 +
|}
 +
===January 2022===
 +
{| style="margin: 10px; background-color:#E4EEF2"
 +
|width=100px|{{#pwImage:Pathway:WP722|250px||Serotonin HTR1 group and FOS pathway (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP2152|250px||BDNF pathway (Mus musculus)}}
 +
|width=100px|{{#pwImage:Pathway:WP2435|250px||Quercetin and Nf-kB / AP-1 induced apoptosis (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP3953|250px||mRNA, protein, and metabolite inducation pathway by cyclosporin A (Homo sapiens)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP4238|250px||Flavan-3-ol metabolic pathway (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP4316|250px||miRNA degrading enzymes (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP4630|250px||Measles virus infection (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5133|250px||Non-classical role of vitamin D (Homo sapiens)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5156|250px||SARS-CoV-2 replication organelle formation (Homo sapiens)}}
 +
|}
 +
===December 2021===
 +
{| style="margin: 10px; background-color:#E4EEF2"
 +
|width=100px|{{#pwImage:Pathway:WP4941|250px||GPR143 in melanocytes and retinal pigment epithelium cells (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5043|250px||Pentose phosphate pathway in senescent cells (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5070|250px||Salmonella virulence regulatory network (Escherichia coli)}}
 +
|width=100px|{{#pwImage:Pathway:WP5144|250px||NRP1-triggered signaling pathways in pancreatic cancer (Homo sapiens)}}
 +
|}
 +
===September 2021===
 +
{| style="margin: 10px; background-color:#E4EEF2"
 +
|width=100px|{{#pwImage:Pathway:WP5085|250px||Vasopressin-regulated water reabsorption (Homo sapiens)}}
 +
|}
 +
===August 2021===
 +
{| style="margin: 10px; background-color:#E4EEF2"
 +
|width=100px|{{#pwImage:Pathway:WP5036|250px||Angiotensin II receptor type 1 pathway (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5055|250px||Burn wound healing (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5056|250px||Burn Wound Healing (Mus musculus)}}
 +
|width=100px|{{#pwImage:Pathway:WP5087|250px||Malignant pleural mesothelioma (Homo sapiens)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5057|250px||Burn wound healing (Rattus norvegicus)}}
 +
|width=100px|{{#pwImage:Pathway:WP5089|250px||Kinin-Kallikrein pathway (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5115|250px||Network map of SARS-CoV-2 signaling pathway (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5118|250px||SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome (Homo sapiens)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5088|250px||Prostaglandin signaling (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5094|250px||Orexin receptor pathway (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5095|250px||Overview of proinflammatory and profibrotic mediators (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5097|250px||CCL18 signaling pathway (Homo sapiens)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5114|250px||Nucleotide excision repair in xeroderma pigmentosum (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5117|250px||Cohesin complex - Cornelia de Lange syndrome (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5119|250px||NIPBL role in DNA damage - Cornelia de Lange syndrome (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5121|250px||Sphingolipid metabolism in senescence (Homo sapiens)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5122|250px||Prostaglandin and leukotriene metabolism in senescence (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5128|250px||Fibrin complement receptor 3 signaling pathway (Mus musculus)}}
 +
|}
 +
===July 2021===
 +
{| style="margin: 10px; background-color:#E4EEF2"
 +
|width=100px|{{#pwImage:Pathway:WP5023|250px||Hypoxia-dependent self-renewal of myoblasts (Mus musculus)}}
 +
|width=100px|{{#pwImage:Pathway:WP5024|250px||Hypoxia-dependent proliferation of myoblasts (Mus musculus)}}
 +
|width=100px|{{#pwImage:Pathway:WP5025|250px||Hypoxia-dependent differentiation of myoblasts (Mus musculus)}}
 +
|width=100px|{{#pwImage:Pathway:WP5120|250px||Inclusion body myositis (Homo sapiens)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5108|250px||Familial hyperlipidemia type 1 (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5109|250px||Familial hyperlipidemia type 2 (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5110|250px||Familial hyperlipidemia type 3 (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5111|250px||Familial hyperlipidemia type 4 (Homo sapiens)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5098|250px||T-cell activation SARS-CoV-2 (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5101|250px||Congenital generalized lipodystrophy (CGL) (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5102|250px||Familial partial lipodystrophy (FPLD) (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5103|250px||Progeria-associated lipodystrophy (Homo sapiens)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5112|250px||Familial hyperlipidemia type 5 (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5104|250px||Acquired partial lipodystrophy / Barraquer-Simons syndrome (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5113|250px||Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5124|250px||Alzheimer's disease (Homo sapiens)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5116|250px||SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5105|250px||Meta pathway lipodystrophy, dyslipidemia and hyperlipidemia (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5092|250px||Interactions of natural killer cells in pancreatic cancer (Homo sapiens)}}
 +
|}
 +
===June 2021===
 +
{| style="margin: 10px; background-color:#E4EEF2"
 +
|width=100px|{{#pwImage:Pathway:WP5033|250px||Genes associated with the development of rheumatoid arthritis (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5083|250px||Neuroinflammation and glutamatergic signaling (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5090|250px||Complement system in neuronal development and plasticity (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP38|250px||Fatty acid biosynthesis (Caenorhabditis elegans)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP810|250px||Hepatocyte growth factor receptor signaling (Gallus gallus)}}
 +
|width=100px|{{#pwImage:Pathway:WP927|250px||Hepatocyte growth factor receptor signaling (Pan troglodytes)}}
 +
|width=100px|{{#pwImage:Pathway:WP1162|250px||Hepatocyte growth factor receptor signaling (Canis familiaris)}}
 +
|width=100px|{{#pwImage:Pathway:WP1198|250px||S1P receptor signal transduction (Canis familiaris)}}
 +
|}
 +
===May 2021===
 +
{| style="margin: 10px; background-color:#E4EEF2"
 +
|width=100px|{{#pwImage:Pathway:WP4688|250px||Serine Metabolism (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5060|250px||Peptidoglycan cytoplasmic synthesis and recycling pathways (Escherichia coli)}}
 +
|width=100px|{{#pwImage:Pathway:WP5066|250px||FOXA2 pathway (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5072|250px||Modulators of TCR signaling and T cell activation (Homo sapiens)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5074|250px||Kallmann's Syndrome (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5061|250px||Fatty acid transporters (Homo sapiens)}}
 +
|}
 +
===April 2021===
 +
{| style="margin: 10px; background-color:#E4EEF2"
 +
|width=100px|{{#pwImage:Pathway:WP5063|250px||FOXP3 in COVID-19 (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5065|250px||SARS-CoV-2 altering angiogenesis via NRP1 (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5076|250px||Soluble ACE2-mediated cell entry of SARS-CoV-2 (Homo sapiens)}}
 +
|}
 +
===March 2021===
 +
{| style="margin: 10px; background-color:#E4EEF2"
 +
|width=100px|{{#pwImage:Pathway:WP2839|250px||Hair Follicle Development: Organogenesis - Part 2 of 3 (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP4010|250px||Liver steatosis AOP (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5027|250px||nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5044|250px||Kynurenine Pathway and links to Cellular Senescence (Homo sapiens)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5046|250px||NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5052|250px||Nephrogenesis (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5053|250px||Development of ureteric collection system (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5064|250px||7-oxo-C and 7beta-HC pathways (Homo sapiens)}}
 +
|}
 +
===February 2021===
 +
{| style="margin: 10px; background-color:#E4EEF2"
 +
|width=100px|{{#pwImage:Pathway:WP4962|250px||Airway smooth muscle cell contraction (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5038|250px||SARS-CoV-2 mitochondrial interactions (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5039|250px||SARS-CoV-2 Innate Immunity Evasion and Cell-specific immune response (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5049|250px||Glycolysis in senescence (Homo sapiens)}}
 +
|-
 +
|width=100px|{{#pwImage:Pathway:WP5050|250px||TCA cycle in senescence (Homo sapiens)}}
 +
|}
 +
===January 2021===
 +
{| style="margin: 10px; background-color:#E4EEF2"
 +
|width=100px|{{#pwImage:Pathway:WP4317|250px||Mitochondrial fatty acid synthesis pathway (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5030|250px||Ethylmalonic Encephalopathy (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5031|250px||Biotin Metabolism (including IEMs) (Homo sapiens)}}
 +
|width=100px|{{#pwImage:Pathway:WP5037|250px||Riboflavin and CoQ disorders (Homo sapiens)}}
 +
|}
 +
 +
 +
=== Prior Years ===
 +
* [[WikiPathways:NewPathwayReleases2020|2020]]
 +
* [[WikiPathways:NewPathwayReleases2019|2019]]
 +
* [[WikiPathways:NewPathwayReleases2018|2018]]
 +
* [[WikiPathways:NewPathwayReleases2017|2017]]

Current revision

Each month there are new pathways reviewed and approved for the official release of WikiPathways. See the Download Page to access the full collection.

Contents

January 2023

Image does not exist
Response to acute ibuprofen exposure (Daphnia magna)
Image does not exist
Estrogen metabolism (Homo sapiens)
Image does not exist
Ganglio series sphingolipid metabolism (Homo sapiens)
Image does not exist
Lacto series sphingolipid metabolism (Homo sapiens)
Image does not exist
Glucocorticoid biosynthesis (Homo sapiens)
Image does not exist
Lipid remodeling (Anopheles gambiae)
Image does not exist
Glycosphingolipid metabolism (Homo sapiens)
Image does not exist
Steroid hormone precursor biosynthesis (Homo sapiens)
Image does not exist
TROP2 regulatory signaling (Homo sapiens)
Image does not exist
Neolacto series sphingolipid metabolism (Homo sapiens)
Image does not exist
Mineralocorticoid biosynthesis (Homo sapiens)

December 2022

Image does not exist
Extrafollicular and follicular B cell activation by SARS-CoV-2 (Homo sapiens)

November 2022

Image does not exist
T cell modulation in pancreatic cancer (Homo sapiens)
Image does not exist
Arachidonic acid (AA, ARA) oxylipin metabolism (Homo sapiens)
Image does not exist
Markers of kidney cell lineage (Homo sapiens)
Image does not exist
Comprehensive IL-17A signaling pathway (Mus musculus)
Image does not exist
Cell interactions of the pancreatic cancer microenvironment (Homo sapiens)
Image does not exist
17q12 copy number variation syndrome (Homo sapiens)
Image does not exist
Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins (Homo sapiens)
Image does not exist
Sildenafil treatment (Homo sapiens)

October 2022

Image does not exist
Chronic hyperglycemia impairment of neuron function (Homo sapiens)
Image does not exist
Serotonin reuptake inhibitor response (Daphnia magna)
Image does not exist
Endothelial cell senescence (Homo sapiens)
Image does not exist
Ether lipid biosynthesis (Homo sapiens)
Image does not exist
Frustrated phagocytosis leading to malignant pleural mesothelioma (Homo sapiens)
Image does not exist
Immune infiltration in pancreatic cancer (Homo sapiens)

September 2022

Image does not exist
Triacylglyceride synthesis (Gallus gallus)

August 2022

Image does not exist
Hippocampal synaptogenesis and neurogenesis (Homo sapiens)
Image does not exist
Arsenic metabolism and reactive oxygen species generation (Homo sapiens)
Image does not exist
Bardet-Biedl syndrome (Homo sapiens)
Image does not exist
Estradiol regulation in Porto-Sinusoidal Vascular Disease (Homo sapiens)
Image does not exist
Cholestasis (Homo sapiens)
Image does not exist
Neurogenesis regulation in the olfactory epithelium (Homo sapiens)
Image does not exist
Genetic causes of PSVD/INCPH (Homo sapiens)
Image does not exist
Bacterial ceramide synthesis (Caulobacter vibrioides)
Image does not exist
LDL- influence on CD14 and TLR4 (Homo sapiens)
Image does not exist
Effect of intestinal microbiome on anticoagulant response of Vitamin K antagonists (Homo sapiens)
Image does not exist
Farnesyl to CoQ10 metabolism (Homo sapiens)

July 2022

Image does not exist
Lac-Phe pathway (Homo sapiens)
Image does not exist
Lac-Phe pathway (Mus musculus)
Image does not exist
Mitochondrial beta oxidation (Homo sapiens)

June 2022

Image does not exist
2q11.2 copy number variation syndrome (Homo sapiens)

May 2022

Image does not exist
Leucine, isoleucine and valine metabolism (Homo sapiens)
Image does not exist
Metabolic reprogramming in pancreatic cancer (Homo sapiens)
Image does not exist
2q13 copy number variation syndrome (Homo sapiens)
Image does not exist
2q21.1 copy number variation syndrome (Homo sapiens)
Image does not exist
2q37 copy number variation syndrome (Homo sapiens)

April 2022

Image does not exist
Docosahexaenoic acid (DHA) oxylipin metabolism (Homo sapiens)
Image does not exist
Metabolic pathway leukotriene (Homo sapiens)
Image does not exist
DYRK1A (Homo sapiens)
Image does not exist
Roles of ceramides in the development of insulin resistance (Homo sapiens)
Image does not exist
Pro-survival signaling of neuroprotectin D1 (Homo sapiens)
Image does not exist
Activation of Vitamin K-dependent proteins (Homo sapiens)
Image does not exist
Retinol Metabolism (Homo sapiens)
Image does not exist
Creatine Pathway (Homo sapiens)
Image does not exist
ResolvinE1 and ResolvinD1 signaling pathways promoting inflammation resolution (Homo sapiens)
Image does not exist
Modulation of the PI3K-Akt-mTOR signaling by bioactive sphingolipids (Homo sapiens)
Image does not exist
Cholesterol synthesis disorders (Homo sapiens)
Image does not exist
Synthesis of ceramides and 1-deoxyceramides (Homo sapiens)
Image does not exist
N-Glycan biosynthesis (Sheep) (Ovis aries)
Image does not exist
PtdIns(4,5)P2 in cytokinesis pathway (Homo sapiens)
Image does not exist
Dravet syndrome (Homo sapiens)
Image does not exist
Phospholipid biosynthesis (Saccharomyces cerevisiae)
Image does not exist
Alstrom syndrome (Homo sapiens)
Image does not exist
Clocked controlled autophagy in bone metabolism (Homo sapiens)
Image does not exist
Glucose metabolism in triple-negative breast cancer cells (Homo sapiens)
Image does not exist
Amino acid metabolism in triple-negative breast cancer cells (Homo sapiens)
Image does not exist
Extrafollicular B cell activation by SARS-CoV-2 (Homo sapiens)

March 2022

Image does not exist
Th17 cell differentiation pathway (Homo sapiens)
Image does not exist
ALA oxylipin metabolism (Homo sapiens)
Image does not exist
Linoleic acid oxylipin metabolism (Homo sapiens)
Image does not exist
GDNF signaling (Homo sapiens)
Image does not exist
Lipid metabolism in senescent cells (Homo sapiens)
Image does not exist
Glyoxylate metabolism (Homo sapiens)
Image does not exist
Hemesynthesis defects and porphyrias (Homo sapiens)
Image does not exist
Disorders of galactose metabolism (Homo sapiens)
Image does not exist
Ulcerative colitis signaling (Homo sapiens)
Image does not exist
Disorders in ketone body synthesis (Homo sapiens)
Image does not exist
Disorders of bile acid synthesis and biliary transport (Homo sapiens)
Image does not exist
Disorders of fructose metabolism (Homo sapiens)
Image does not exist
Biosynthesis and turnover of 1-deoxy-sphingoid bases (Homo sapiens)
Image does not exist
SARS-CoV-2 Mediated Endothelial Dysfunction: The Potential Role of Chronic Oxidative Stress in the mitochondria (Homo sapiens)
Image does not exist
mRNA vaccine activation of Dendritic cell and induction of IFN-1 (Homo sapiens)
Image does not exist
Copper metabolism (Homo sapiens)
Image does not exist
Disorders in Ketolysis (Homo sapiens)
Image does not exist
Inflammatory bowel disease signaling (Homo sapiens)

January 2022

Image does not exist
Serotonin HTR1 group and FOS pathway (Homo sapiens)
Image does not exist
BDNF pathway (Mus musculus)
Image does not exist
Quercetin and Nf-kB / AP-1 induced apoptosis (Homo sapiens)
Image does not exist
mRNA, protein, and metabolite inducation pathway by cyclosporin A (Homo sapiens)
Image does not exist
Flavan-3-ol metabolic pathway (Homo sapiens)
Image does not exist
miRNA degrading enzymes (Homo sapiens)
Image does not exist
Measles virus infection (Homo sapiens)
Image does not exist
Non-classical role of vitamin D (Homo sapiens)
Image does not exist
SARS-CoV-2 replication organelle formation (Homo sapiens)

December 2021

Image does not exist
GPR143 in melanocytes and retinal pigment epithelium cells (Homo sapiens)
Image does not exist
Pentose phosphate pathway in senescent cells (Homo sapiens)
Image does not exist
Salmonella virulence regulatory network (Escherichia coli)
Image does not exist
NRP1-triggered signaling pathways in pancreatic cancer (Homo sapiens)

September 2021

Image does not exist
Vasopressin-regulated water reabsorption (Homo sapiens)

August 2021

Image does not exist
Angiotensin II receptor type 1 pathway (Homo sapiens)
Image does not exist
Burn wound healing (Homo sapiens)
Image does not exist
Burn Wound Healing (Mus musculus)
Image does not exist
Malignant pleural mesothelioma (Homo sapiens)
Image does not exist
Burn wound healing (Rattus norvegicus)
Image does not exist
Kinin-Kallikrein pathway (Homo sapiens)
Image does not exist
Network map of SARS-CoV-2 signaling pathway (Homo sapiens)
Image does not exist
SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome (Homo sapiens)
Image does not exist
Prostaglandin signaling (Homo sapiens)
Image does not exist
Orexin receptor pathway (Homo sapiens)
Image does not exist
Overview of proinflammatory and profibrotic mediators (Homo sapiens)
Image does not exist
CCL18 signaling pathway (Homo sapiens)
Image does not exist
Nucleotide excision repair in xeroderma pigmentosum (Homo sapiens)
Image does not exist
Cohesin complex - Cornelia de Lange syndrome (Homo sapiens)
Image does not exist
NIPBL role in DNA damage - Cornelia de Lange syndrome (Homo sapiens)
Image does not exist
Sphingolipid metabolism in senescence (Homo sapiens)
Image does not exist
Prostaglandin and leukotriene metabolism in senescence (Homo sapiens)
Image does not exist
Fibrin complement receptor 3 signaling pathway (Mus musculus)

July 2021

Image does not exist
Hypoxia-dependent self-renewal of myoblasts (Mus musculus)
Image does not exist
Hypoxia-dependent proliferation of myoblasts (Mus musculus)
Image does not exist
Hypoxia-dependent differentiation of myoblasts (Mus musculus)
Image does not exist
Inclusion body myositis (Homo sapiens)
Image does not exist
Familial hyperlipidemia type 1 (Homo sapiens)
Image does not exist
Familial hyperlipidemia type 2 (Homo sapiens)
Image does not exist
Familial hyperlipidemia type 3 (Homo sapiens)
Image does not exist
Familial hyperlipidemia type 4 (Homo sapiens)
Image does not exist
T-cell activation SARS-CoV-2 (Homo sapiens)
Image does not exist
Congenital generalized lipodystrophy (CGL) (Homo sapiens)
Image does not exist
Familial partial lipodystrophy (FPLD) (Homo sapiens)
Image does not exist
Progeria-associated lipodystrophy (Homo sapiens)
Image does not exist
Familial hyperlipidemia type 5 (Homo sapiens)
Image does not exist
Acquired partial lipodystrophy / Barraquer-Simons syndrome (Homo sapiens)
Image does not exist
Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway (Homo sapiens)
Image does not exist
Alzheimer's disease (Homo sapiens)
Image does not exist
SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation (Homo sapiens)
Image does not exist
Meta pathway lipodystrophy, dyslipidemia and hyperlipidemia (Homo sapiens)
Image does not exist
Interactions of natural killer cells in pancreatic cancer (Homo sapiens)

June 2021

Image does not exist
Genes associated with the development of rheumatoid arthritis (Homo sapiens)
Image does not exist
Neuroinflammation and glutamatergic signaling (Homo sapiens)
Image does not exist
Complement system in neuronal development and plasticity (Homo sapiens)
Image does not exist
Fatty acid biosynthesis (Caenorhabditis elegans)
Image does not exist
Hepatocyte growth factor receptor signaling (Gallus gallus)
Image does not exist
Hepatocyte growth factor receptor signaling (Pan troglodytes)
Image does not exist
Hepatocyte growth factor receptor signaling (Canis familiaris)
Image does not exist
S1P receptor signal transduction (Canis familiaris)

May 2021

Image does not exist
Serine Metabolism (Homo sapiens)
Image does not exist
Peptidoglycan cytoplasmic synthesis and recycling pathways (Escherichia coli)
Image does not exist
FOXA2 pathway (Homo sapiens)
Image does not exist
Modulators of TCR signaling and T cell activation (Homo sapiens)
Image does not exist
Kallmann's Syndrome (Homo sapiens)
Image does not exist
Fatty acid transporters (Homo sapiens)

April 2021

Image does not exist
FOXP3 in COVID-19 (Homo sapiens)
Image does not exist
SARS-CoV-2 altering angiogenesis via NRP1 (Homo sapiens)
Image does not exist
Soluble ACE2-mediated cell entry of SARS-CoV-2 (Homo sapiens)

March 2021

Image does not exist
Hair Follicle Development: Organogenesis - Part 2 of 3 (Homo sapiens)
Image does not exist
Liver steatosis AOP (Homo sapiens)
Image does not exist
nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell (Homo sapiens)
Image does not exist
Kynurenine Pathway and links to Cellular Senescence (Homo sapiens)
Image does not exist
NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence (Homo sapiens)
Image does not exist
Nephrogenesis (Homo sapiens)
Image does not exist
Development of ureteric collection system (Homo sapiens)
Image does not exist
7-oxo-C and 7beta-HC pathways (Homo sapiens)

February 2021

Image does not exist
Airway smooth muscle cell contraction (Homo sapiens)
Image does not exist
SARS-CoV-2 mitochondrial interactions (Homo sapiens)
Image does not exist
SARS-CoV-2 Innate Immunity Evasion and Cell-specific immune response (Homo sapiens)
Image does not exist
Glycolysis in senescence (Homo sapiens)
Image does not exist
TCA cycle in senescence (Homo sapiens)

January 2021

Image does not exist
Mitochondrial fatty acid synthesis pathway (Homo sapiens)
Image does not exist
Ethylmalonic Encephalopathy (Homo sapiens)
Image does not exist
Biotin Metabolism (including IEMs) (Homo sapiens)
Image does not exist
Riboflavin and CoQ disorders (Homo sapiens)


Prior Years

Retrieved from "https://classic.wikipathways.org/index.php/WikiPathways:NewPathwayReleases"
Personal tools